D. Wagner (Freiburg, Germany), M. Pretti Dalcolmo (Rio De Janeiro (RJ), Brazil)
Risk score of drug-induced liver injury among new tuberculosis patients
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation)
|     |
Ursodeoxy cholic acid (UDCA) reverses hepatotoxicity of multidrug treatment of mycobacterial infections
S. Lang (Gera, Germany), S. Rostig (Gera, Germany), H. Schiffl (Gera, Germany)
| |
Efficacy of small-volume plasmapheresis application for MDR/XDR TB patients with medicinal live damag?
A. Samoilova (Moscow, Russian Federation), E. Vaniev (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
The frequency of cases of hepatotoxic reactions in first diagnosed patients with pulmonary tuberculosis
A. Kazakov (Moscow, Russian Federation), G. Mojokina (Moscow, Russian Federation), S. Smerdin (Moscow, Russian Federation), V. Aksenova (Moscow, Russian Federation), N. Klevno (Moscow, Russian Federation)
| |
A review of in-house Video Observed Therapy (VOT) for patients with active tuberculosis(TB), in a London teaching hospital.
K. Manalan (London, United Kingdom), K. Sivakumaran (London, United Kingdom), M. Nayagam (London, United Kingdom), B. Villanueva (London, United Kingdom), C. Cosgrove (London, United Kingdom), A. Dunleavy (London, United Kingdom)
| |
Video observed treatment for tuberculosis patients in Belarus.
A. Skrahina (Minsk, Belarus), H. Sinkou (Minsk, Belarus), V. Akulov (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Story (London, United Kingdom), H. Hurevich (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
| |
Does hospitalization influence tuberculosis’ treatment outcome? – A Portuguese nationwide study
R. Boaventura (Porto, Portugal), J. Santos (Porto, Portugal), J. Viana (Porto, Portugal), A. Freitas (Porto, Portugal), R. Duarte (Porto, Portugal)
| |
Tuberculosis in women: A reflection of gender inequity
K. Srivastava (Lucknow, India), S. Kant (Lucknow, India), A. Narain (Lucknow, India), J. Bajpai (Lucknow, India)
| |
Tuberculosis and tobacco: is there any epidemiological association?
E. de Sousa Antunes Dias Padrão (Porto, Portugal), O. Oliveira (Porto, Portugal), Ó. Felgueiras (Porto, Portugal), A. Gaio (Porto, Portugal), R. Duarte (Porto, Portugal)
| |
Comparative study of tuberculosis in smokers and non-smokers
f. chaaibate (CASABLANCA, Morocco), H. Jabri (CASABLANCA, Morocco), W. Elkhattabi (CASABLANCA, Morocco), H. Afif (CASABLANCA, Morocco)
| |
A new type of mediterranean mycobacteriosis
K. Jahn (Basel, Switzerland), V. Baettig (Basel, Switzerland), H. Seth-Smith (Basel, Switzerland), M. Tamm (Basel, Switzerland), A. Egli (Basel, Switzerland)
| |
Characterization of drug susceptibility of nontuberculous mycobacteria of M.chelonae and M.fortuitum complexes.
M. Makarova (moscow, Russian Federation), . Khachaturiants (moscow, Russian Federation), M. Krasnova (moscow, Russian Federation), K. Galkina (moscow, Russian Federation), J. Mikhailova (moscow, Russian Federation), L. Guntupova (moscow, Russian Federation), V. Litvinov (moscow, Russian Federation)
| |
Drug susceptibility of slowly growing nontuberculous mycobacteria (sNTM) isolated in the European part of Russian Federation
T. Smirnova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), I. Andrievskaya (Moscow, Russian Federation), E. Kiseleva (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation)
| |
Significance of Mycobacterium Avium Complex (MAC) isolation in bronchoscopic samples
E. Tabernero Huguet (Bilbao, Spain), S. Pedrero Tejada (Bilbao, Spain), I. Salinas Garrido (Bilbao, Spain), E. Urra Zabildegoitia (Bilbao, Spain), I. Lopez Aranaga (Bilbao, Spain), R. Zalacain Jorge (Bilbao, Spain)
| |
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
O. Kim (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), Y. Koh (Seoul, Republic of Korea), W. Kim (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), C. Lim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)
| |
The effect of alcohol consumption in the treatment of nontuberculous mycobacteria
M. Jacob (Porto, Portugal), R. Silva (Porto, Portugal), R. Gaio (Porto, Portugal), R. Duarte (Porto, Portugal), B. Ahlers (Bethany.Ahlers@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , C. Hood (Catrina.Hood@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , B. Deng (Bin.Deng@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , Y. Lam (Ying-Wai.Lam@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , E. Beatman (BeatmanE@NJHealth.org / National Jewish Health,Denver, C. , K. Schweitzer (SchweitzerK@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , I. Petrache (PetracheI@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , D. Weiss (daniel.weiss@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , D. Wagner (darcy.wagner@med.lu.se / Lund University,Lund)
| |